NAGE
Niagen Bioscience Inc (NAGE)
Healthcare • NASDAQ • $3.21+1.90%
- Symbol
- NAGE
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $3.21
- Daily Change
- +1.90%
- Market Cap
- $238.96M
- Trailing P/E
- 15.89
- Forward P/E
- 30.20
- 52W High
- $10.52
- 52W Low
- $2.87
- Analyst Target
- $12.08
- Dividend Yield
- N/A
- Beta
- 2.10
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU N…
Company websiteResearch NAGE on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.